ASX:COH

Cochlear Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume201,277 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend Yield1.18%

BetaN/A

Receive COH News and Ratings via Email

Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter.

About Cochlear

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Why has the Cochlear (ASX:COH) share price been struggling lately?
September 23, 2021 | msn.com

Insider Buying: Cochlear Limited (ASX:COH) Insider Purchases 8,991 Shares of Stock
September 10, 2021 | americanbankingnews.com

Insider Selling: Cochlear Limited (ASX:COH) Insider Sells 8,991 Shares of Stock
September 10, 2021 | americanbankingnews.com

Sensorion and Cochlear to Begin First Clinical Trial of SENS-401 for Hearing Preservation in Combination With Cochlear Implantation
September 8, 2021 | businesswire.com

The Cochlear (ASX: COH) share price is up 4% this last week
September 3, 2021 | msn.com

Is Cochlear Limited's (ASX:COH) Recent Stock Performance Influenced By Its Financials In Any Way?
August 23, 2021 | finance.yahoo.com

The Cochlear (ASX:COH) share price tumbles 7% despite dividend boost
August 20, 2021 | msn.com

Cochlear (ASX:COH) share price sinks: How did its result compare to expectations?
August 20, 2021 | msn.com

Cochlear (ASX:COH) share price on watch after hitting FY21 earnings guidance
August 20, 2021 | msn.com

How did the Cochlear (ASX:COH) share price respond last earnings season?
August 18, 2021 | msn.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange ASX
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolASX:COH
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.cochlear.com
Phone+61-2-94286555
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$1.50 billion
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow123.45
Book ValueA$25.88 per share
Price / BookN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableOptionable

MarketRank^™

Overall MarketRank^™

1.41 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Cochlear.

3.7 Community Rank

Outperform Votes
Cochlear has received 165 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cochlear has received 125 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cochlear has received 56.90% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cochlear and other stocks. Vote “Outperform” if you believe COH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe COH will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Yield
Cochlear pays a meaningful dividend of 1.18%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Cochlear does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Cochlear is 56.37%. This payout ratio is at a healthy, sustainable level, below 75%.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cochlear insiders have bought 22.61% more of their company's stock than they have sold. Specifically, they have bought A$2,615,287.00 in company stock and sold A$2,132,935.00 in company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Cochlear (ASX:COH) Frequently Asked Questions

What stocks does MarketBeat like better than Cochlear?

Wall Street analysts have given Cochlear a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cochlear wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Cochlear's earnings last quarter?

Cochlear Limited (ASX:COH) posted its quarterly earnings data on Tuesday, February, 19th. The company reported $2.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.19 by $0.04.
View Cochlear's earnings history.

How often does Cochlear pay dividends? What is the dividend yield for Cochlear?

Cochlear announced a Final dividend on Monday, August 23rd. Shareholders of record on Sunday, October 17th will be paid a dividend of 1.40 per share on Sunday, October 17th. This represents a dividend yield of 0.58%. The ex-dividend date is Wednesday, September 22nd.
View Cochlear's dividend history.

Is Cochlear a good dividend stock?

Cochlear pays an annual dividend of A$2.80 per share and currently has a dividend yield of 1.18%. The dividend payout ratio of Cochlear is 56.37%. This payout ratio is at a healthy, sustainable level, below 75%.
View Cochlear's dividend history.

Who are Cochlear's key executives?

Cochlear's management team includes the following people:

Mr. Diggory William Howitt BE (Hons), MBA, CEO, MD, Pres & Exec. Director (Age 54, Pay $2.08M)
Mr. Jan Janssen, Chief Technology Officer (Age 56, Pay $971.19k)
Mr. Richard Brook, Pres of EMEA & Latin American Region
Mr. Anthony Manna, Pres of Americas Region
Mr. Anthony Bishop, Pres of Asia Pacific Region
Mr. Stuart Sayers, CFO & Pres of Services
Mr. David Hackshall, Chief Information Officer
Ms. Kristina Devon, VP of Investor Relations
Ms. Jennifer Stevenson, VP of Corp. Communications
Mr. Dean Phizacklea, Sr. VP of Global Marketing

Who are some of Cochlear's key competitors?

Some companies that are related to Cochlear include 4DMedical (4DX), Adherium (ADR), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics (AMT), Analytica (ALT), AnteoTech (ADO), Anteris Technologies (AVR), Asensus Surgical (ASXC), Atomo Diagnostics (AT1), AVITA Medical (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), CleanSpace (CSX), Cochlear (CHEOY) and Cochlear (CHEOF).
View all of COH's competitors.

What other stocks do shareholders of Cochlear own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cochlear investors own include iShares S&P 500 ETF (IVV), CSL (CSL), ResMed (RMD), Rio Tinto Group (RIO), Altium (ALU), Abbott Laboratories (ABT), Afterpay (APT), Appen (APX), Cross Timbers Royalty Trust (CRT) and Janus Henderson Group (HGG).

What is Cochlear's stock symbol?

Cochlear trades on the ASX under the ticker symbol "COH."

How much money does Cochlear make?

Cochlear has a market capitalization of $0.00 and generates $1.50 billion in revenue each year.

How many employees does Cochlear have?

Cochlear employs 4,000 workers across the globe.

What is Cochlear's official website?

The official website for Cochlear is www.cochlear.com.

Where are Cochlear's headquarters?

Cochlear is headquartered at 1 University Avenue Macquarie University, SYDNEY, NSW 2109, Australia.

How can I contact Cochlear?

Cochlear's mailing address is 1 University Avenue Macquarie University, SYDNEY, NSW 2109, Australia. The company can be reached via phone at +61-2-94286555.

This page was last updated on 9/23/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Cochlear Stock Forecast, Price & News

About Cochlear

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

3.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment